HS 300490 in Trade Records: Observed Product Descriptions and Company Names
What the recorded product descriptions show
HS 300490 appears in the available trade information through three product description strings. They include references to human pharmaceutical products, healthcare products, and veterinary medicine. For example, one record states: HARMLESS PHARMACEUTICAL MEDICINE AND HEALTHCARE PRODUCTS FOR HUMAN CONSUMPTION AS PER INVOICE MENTIONED
. Another says: VETERINARY MEDICINE / VETERINARY MEDICINAL PREPARATION NOT FOR HUMAN USE FOR VETERINARY USE ONLY. NOT ELSEWHERE SPECIFIE
. These descriptions help show the practical scope of goods filed under this heading within the dataset, but they do not provide an official tariff definition.
Because the input does not include an official tariff text for 300490, this page avoids treating the product descriptions as a legal definition. Instead, the evidence shows the types of goods that appear in the records under this heading.
Companies observed in the records
The database includes the following company names under HS 300490:
- PHILRX PHARMA INC.
- B. BRAUN AVITUM PHILIPPINES INC.
- ABBOTT LABORATORIES DE COLOMBIA S.A.
- FRESENIUS MEDICAL CARE PHILS INC.
- FRESENIUS MEDICAL CARE SAS
These names are presented as they appear in the records. They are not linked to specific product descriptions in the available data, so the page does not claim that any one of these companies filed a particular product text.
How to use this information for classification checks
The practical value of these examples is not to copy the wording or assume that a large company’s filing must be correct. Instead, the records can be used as cross-check material when reviewing your own product description under HS 300490. For example, if a product is for human therapeutic use, descriptions in the data emphasize “for human consumption” and “pharmaceutical medicine”; if the product is for veterinary use only, the records show a separate description marking “not for human use.” These are useful points to compare with the actual composition, dose form, and retail packaging of the goods you are classifying.
However, historical filings do not prove a classification is correct, and copying another company’s description does not by itself reduce misclassification risk. The safer approach is to use these observed description patterns to ask whether your product includes the necessary details—such as human or veterinary use, pharmaceutical status, and dosage form—before submitting a classification decision.
Practical limits
The provided material contains a company list and a product-description list for the same HS code, but does not pair them. It also does not include official tariff definitions, applicable country-specific rules, or data about shipment volumes, dates, or origins. Therefore, this page is limited to describing the visible filing patterns and cannot verify whether any specific entry was correctly classified.
Data notes
This page was automatically generated from the available trade information. The analysis covers only the company names and product description strings supplied for HS 300490. No official tariff definition, customs decision, or country-specific rule was provided, and no external database or registry was consulted.
